Azelaic acid: risk management plan summary for Milenon gel
The available description outlines risk minimization through prescribing and packaging information and ongoing pharmacovigilance. The absence of identified significant risks in the plan should not be interpreted as an absence of adverse reactions.
#azelaic acid dec.gov.ua